We Make Medicine


At Teva Canada, we believe that all Canadians deserve access to innovative and affordable medications. We develop, produce and market generic pharmaceuticals, from diabetic agents to antibiotics, from heart medications to cancer treatments. We’ve been part of Canadian healthcare since 1965, when we began operations as one of the country’s first generic pharmaceutical companies. Today, we employ over 1,300 Canadians. We invest in facilities in this country—creating generic and brand-name medications. And we’re proud to be part of Teva Pharmaceutical Industries Ltd. Worldwide, Teva is the leader in generics, one of the top 10 pharmaceutical companies, active in 60 countries and a workplace of choice for 46,000 dedicated employees.

We are motivated by a passion to make a difference.


GM March 30, 2015

Doug Sommerville announces the launch of PrBortezomib for injection, a generic of PrVelcade®

"Our litigation success in bringing PrBortezomib for Injection to market sooner will save Canadian hospitals millions of dollars." > more

July 10, 2015

Introducing PrTeva-Progesterone. 
A generic alternative to PrPrometrium®

Product information and complete product monograph available. > more